PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Lisinopril - Hypertension

PAD Profile : Lisinopril - Hypertension Important

Keywords :
ACE inhibitors, high blood pressure, raised blood pressure
Brand Names Include :
Zestril
Important Information :
Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.

Traffic Light Status

Status 1 of 2.

Status :
Green
Formulations :
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Green (see narrative)
Important
Formulations :
  • Oral solution
Important Information :
Liquid is very expensive (>£200 for 150ml - Drug Tariff Sep 2024).
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC lisinopril has been considered by the PCN and has been assigned a GREEN traffic light status. NOTE - the branded product, Zestril, was considered BLACK at the PCN in May 2017.

Associated BNF Codes

02. Cardiovascular System
02.05.05. Renin-angiotensin system drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More